1
|
Suárez-Cuenca JA, Domínguez-Pérez GA, Hernández-Muñóz RE, Hernández-Patricio A, Vera-Gómez E, Gutiérrez-Buendía JA, Salamanca-García M, Montoya-Ramírez J, Gaytán-Fuentes OF, Aranda-Rodríguez C, Rojas-Noverón AR, García S, Mondragón-Terán P. Nonalcoholic Fatty Liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than Liver Tissue-Measured Nitrogen Metabolism Biomarkers in Population with Obesity and Metabolic Syndrome. Metab Syndr Relat Disord 2023; 21:115-121. [PMID: 36787445 DOI: 10.1089/met.2022.0007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
Abstract
Background: The metabolic syndrome (MS) is associated with an increased production of nitrogen metabolites and elevated oxidative stress, which favors progression of nonalcoholic fatty liver disease (NAFLD). Subjects with the phenotype known as metabolically unhealthy obese (MUO) meet most of the MS cardiometabolic risk criteria and show a higher risk of advanced NAFLD severity, compared with the so-widely known metabolically healthy obese (MHO). Obese individuals with MS are more susceptible to abnormal lipid accumulation in different tissues, whereas oxidative stress and nitrogen metabolites are increased in MS and/or obesity. This study aimed to explore whether plasma- or liver tissue-determined biomarkers of nitrogen metabolism and oxidative stress relate to NAFLD severity and/or metabolic phenotype. Methods: This cross-sectional study included candidates for bariatric surgery with biopsy-proven NAFLD diagnosis and staging. For comparison, the study population was divided according to NAFLD damage (steatohepatitis F0-F1 vs. steatohepatitis F2-F4) and metabolic phenotype (MHO vs MUO, based on the MS criteria). Hepatic and plasma concentrations of nitrogen metabolites and oxidative stress biomarkers were determined by enzymatic kinetics assays, enzyme-linked immunosorbent assay, and Greiss reaction. Results: The study population (N = 45) was constituted by patients with obesity and higher prevalence of dyslipidemia, diabetes mellitus, and hypertension. According to plasma biomarkers, MUO phenotype was related to higher cardiometabolic risk; meanwhile, advanced NAFLD damage was related to higher glycated hemoglobin (HbA1c) and triglycerides. Elevated hepatic concentrations of ammonium, nitrites, arginine, and citrulline were found in MUO phenotype, but only higher plasma concentration of malondialdehyde was found as specifically related to advanced NAFLD damage. Conclusions: Circulating biomarkers of redox state were selectively related to advanced NAFLD damage, suggesting prognostic and therapeutic targets. Hepatic concentrations of nitrogen metabolism biomarkers may be more related to cardiometabolic risk.
Collapse
Affiliation(s)
- Juan Antonio Suárez-Cuenca
- Laboratory of Experimental Metabolism and Clinical Research, Centro Médico Nacional, "20 de Noviembre" ISSSTE, Mexico City, Mexico.,División de Investigación, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre" ISSSTE, Mexico City, Mexico.,Hospital General de Zona No. 32 "Dr. Mario Madrazo Navarro," IMSS, Mexico City, Mexico
| | - Gabriela A Domínguez-Pérez
- Laboratory of Experimental Metabolism and Clinical Research, Centro Médico Nacional, "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Rolando E Hernández-Muñóz
- Cellular and Developmental Biology Department, Institute of Cellular Phyosiology, UNAM, Ciudad Universitaria, Mexico City, Mexico
| | - Alejandro Hernández-Patricio
- Laboratory of Experimental Metabolism and Clinical Research, Centro Médico Nacional, "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Eduardo Vera-Gómez
- Laboratory of Experimental Metabolism and Clinical Research, Centro Médico Nacional, "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Juan A Gutiérrez-Buendía
- Laboratory of Experimental Metabolism and Clinical Research, Centro Médico Nacional, "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Moisés Salamanca-García
- Department of Pathology, Centro Médico Nacional "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Jesús Montoya-Ramírez
- Department of Bariatric Surgery, Centro Médico Nacional "20 de Noviembre," ISSSTE, Mexico City, Mexico
| | - Omar F Gaytán-Fuentes
- Department of Bariatric Surgery, Centro Médico Nacional "20 de Noviembre," ISSSTE, Mexico City, Mexico
| | - Carolina Aranda-Rodríguez
- Laboratory of Experimental Metabolism and Clinical Research, Centro Médico Nacional, "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Amy R Rojas-Noverón
- Laboratory of Experimental Metabolism and Clinical Research, Centro Médico Nacional, "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Silvia García
- División de Investigación, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre" ISSSTE, Mexico City, Mexico
| | - Paul Mondragón-Terán
- Research Coordination, Centro Médico Nacional "20 de Noviembre," ISSSTE, Mexico City, Mexico
| |
Collapse
|
2
|
Melchor-López A, Suárez-Cuenca JA, Banderas-Lares DZ, De la Peña-Sosa G, Salamanca-García M, Vera-Gómez E, Hernández-Patricio A, Gutiérrez-Buendía JA, Zamora-Alemán CR, Alcaráz-Estrada SL, Ortiz-Fernández M, Montoya-Ramírez J, Felipe Gaytán-Fuentes O, Escamilla-Tilch M, Pineda-Juárez JA, Antonio Téllez-González M, Rodríguez-Arellano ME, Contreras-Ramos A, Hernández-Muñoz RE, Gutiérrez-Salinas J, García S, Mondragón-Terán P. The metabolic phenotype of the patient influences the reduction in carotid intima-media thickness achieved following metabolic surgery. J Int Med Res 2022; 50:3000605221137475. [DOI: 10.1177/03000605221137475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Objectives To determine whether metabolic phenotype is associated with the change in carotid intima-media thickness (CIMT) in patients undergoing bariatric /metabolic surgery (BMS). Methods We performed a case-control study of BMS candidates who had metabolically unhealthy obesity (MUO) or metabolically healthy obesity (MHO). We measured the change in CIMT during the 9 months following BMS. The plasma tumor necrosis factor-α, interleukin-1β, adiponectin, leptin, nitric oxide (NO), vascular endothelial growth factor A (VEGF-A), and malondialdehyde concentrations were determined, adipocyte area was measured histologically, and adipose tissue area was estimated using computed tomography. Results Fifty-six patients (mean age 44.5 years, mean body mass index 44.9 kg/m2, 53% women, and 53% had MUO) were studied. Nine months following BMS, the MUO phenotype was not associated with a significant reduction in CIMT, and that of the MHO group was larger. In addition, fewer participants achieved a 10% reduction in CIMT in the MUO group. A CIMT reduction was associated with lower VEGF-A and NO in the MUO group, while that in the MHO group was associated with a higher NO concentration. Conclusion The metabolic phenotype of patients may influence their change in CIMT following BMS, probably through circulating vasodilatory and pro-inflammatory molecules.
Collapse
Affiliation(s)
- Alberto Melchor-López
- Internal Medicine Department, Hospital General “Xoco” SS CDMX, Mexico City, Mexico
- Internal Medicine Department, Instituto Mexicano del Seguro Social, H.G.Z. No. 8 “Gilberto Flores Izquierdo”, and H.G.Z. No. 58 “Manuel Ávila Camacho”, Mexico City, Mexico
| | - Juan Antonio Suárez-Cuenca
- Internal Medicine Department, Hospital General “Xoco” SS CDMX, Mexico City, Mexico
- Internal Medicine Department, Instituto Mexicano del Seguro Social, H.G.Z. No. 8 “Gilberto Flores Izquierdo”, and H.G.Z. No. 58 “Manuel Ávila Camacho”, Mexico City, Mexico
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | - Diana Zaineff Banderas-Lares
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | - Gustavo De la Peña-Sosa
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | | | - Eduardo Vera-Gómez
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | - Alejandro Hernández-Patricio
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | - Juan Ariel Gutiérrez-Buendía
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | - Carlos Ramiro Zamora-Alemán
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | | | - Moisés Ortiz-Fernández
- Bariatric Surgery Department, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City, Mexico
| | - Jesús Montoya-Ramírez
- Bariatric Surgery Department, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City, Mexico
| | | | - Mónica Escamilla-Tilch
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City, Mexico
| | - Juan Antonio Pineda-Juárez
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City, Mexico
| | - Mario Antonio Téllez-González
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City, Mexico
| | | | - Alejandra Contreras-Ramos
- Laboratorio de Biología del Desarrollo y Teratogénesis Experimental, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
| | - Rolando Efraín Hernández-Muñoz
- Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), Coyoacán, Mexico City, Mexico
| | | | - Silvia García
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City. Mexico
| | - Paul Mondragón-Terán
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional “20 de Noviembre” ISSSTE, Mexico City, Mexico
| |
Collapse
|
3
|
Melchor-López A, Suárez-Cuenca JA, Banderas-Lares DZ, Peña-Sosa GDL, Salamanca-García M, Vera-Gómez E, Hernández-Patricio A, Gutiérrez-Buendía JA, Zamora-Alemán CR, Alcaráz-Estrada SL, Ortiz-Fernández M, Montoya-Ramírez J, Gaytán-Fuentes OF, Pérez-Cabeza de Vaca R, Escamilla-Tilch M, Pineda-Juárez JA, Téllez-González MA, Mondragón-Terán P, Rodríguez-Arellano ME, Contreras-Ramos A, García S, Hernández-Muñoz RE. Identification of adipose tissue-related predictors of the reduction in cardiovascular risk induced by metabolic surgery. J Int Med Res 2021; 49:3000605211012569. [PMID: 34024182 PMCID: PMC8150427 DOI: 10.1177/03000605211012569] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Objectives We aimed to determine whether parameters associated with adipose tissue (adipocyte density and the circulating concentrations of markers of adipose tissue pathology) predict cardiovascular risk (CVR) modification after metabolic surgery (MS). Methods We performed a case–control study of patients with morbid obesity who were candidates for MS. CVR was defined using flow-mediated dilation (FMD) and carotid intima media thickness (CIMT), which were measured during the 9 months following MS. Subgroups of CVR reduction were defined using the following cut-offs: CIMT 10% and/or a two-fold increase in FMD. Results We studied 40 patients with morbid obesity (mean age 44.5 years, 75% women, mean body mass index 46.4 kg/m2) and high prevalences of the metabolically unhealthy obesity phenotype, hypertension, and diabetes mellitus. A significant reduction in CVR was associated with lower vascular endothelial growth factor-A concentration (6.20 vs. 1.59 pg/mL, respectively), low adipocyte density in visceral adipose tissue (100 vs. 80 cells/field), low infiltration with CD68+ cells (18 vs. 8 cells/field) and higher concentrations of lipid peroxidation markers and malondialdehyde (313.7 vs. 405.7 ng/mL). Conclusion The characteristics of adipose tissue and the circulating concentrations of markers of adipose pathology might represent useful predictors of the reduction in CVR following MS. Clinical trial registration number: NCT0356198 (https://clinicaltrials.gov)
Collapse
Affiliation(s)
- Alberto Melchor-López
- Internal Medicine Department, Hospital General "Xoco" SS CDMX, Mexico City, Mexico.,Internal Medicine Department, Instituto Mexicano del Seguro Social, H.G.Z. No. 8 "Gilberto Flores Izquierdo", and H.G.Z. "Troncoso", Mexico City, Mexico
| | - Juan Antonio Suárez-Cuenca
- Internal Medicine Department, Hospital General "Xoco" SS CDMX, Mexico City, Mexico.,Internal Medicine Department, Instituto Mexicano del Seguro Social, H.G.Z. No. 8 "Gilberto Flores Izquierdo", and H.G.Z. "Troncoso", Mexico City, Mexico.,Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Diana Zaineff Banderas-Lares
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Gustavo De la Peña-Sosa
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | | | - Eduardo Vera-Gómez
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Alejandro Hernández-Patricio
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Juan Ariel Gutiérrez-Buendía
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Carlos Ramiro Zamora-Alemán
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | | | - Moisés Ortiz-Fernández
- Bariatric Surgery Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Jesús Montoya-Ramírez
- Bariatric Surgery Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | | | - Rebeca Pérez-Cabeza de Vaca
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Mónica Escamilla-Tilch
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Juan Antonio Pineda-Juárez
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Mario Antonio Téllez-González
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Paul Mondragón-Terán
- Tissue Engineering & Regenerative Medicine Research Group, Coordinación de Investigación, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | | | - Alejandra Contreras-Ramos
- Laboratorio de Biología del Desarrollo y Teratogénesis Experimental, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
| | - Silvia García
- Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico
| | - Rolando Efraín Hernández-Muñoz
- Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular; Universidad Nacional Autónoma de México (UNAM), Coyoacán, Mexico City, Mexico
| |
Collapse
|
4
|
Suárez-Cuenca JA, De La Peña-Sosa G, De La Vega-Moreno K, Banderas-Lares DZ, Salamanca-García M, Martínez-Hernández JE, Vera-Gómez E, Hernández-Patricio A, Zamora-Alemán CR, Domínguez-Pérez GA, Ruíz-Hernández AS, Gutiérrez-Buendía JA, Melchor-López A, Ortíz-Fernández M, Montoya-Ramírez J, Gaytán-Fuentes OF, Toríz-Ortíz A, Osorio-Valero M, Orozco-Vázquez J, Alcaráz-Estrada SL, Rodríguez-Arellano ME, Maldonado-Arriaga B, Pérez-Cabeza de Vaca R, Escamilla-Tilch M, Pineda-Juárez JA, Téllez-González MA, García S, Mondragón-Terán P. Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity. Sci Rep 2021; 11:1831. [PMID: 33469087 PMCID: PMC7815822 DOI: 10.1038/s41598-021-81289-2] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2020] [Accepted: 12/30/2020] [Indexed: 12/20/2022] Open
Abstract
Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT) and peripheral blood were obtained from obese patients submitted to bariatric surgery. Adipose tissue (morphometry), plasma adiponectin, TNF-α, resistin (multiplexing) and biochemical chemistry were analyzed; as well as endothelial dysfunction (Flow Mediated Dilation, FMD) and atherogenesis (Carotid Intima Media Thickness, CIMT). Subgroups divided by adipocyte size and source were compared; as well as correlation and multivariate analysis. Sixty patients 36.6% males, aged 44 years-old, BMI 46.7 kg/m2 were included. SAT's adipocytes showed a lower range of size expandability than VAT's adipocytes. Independent from their source, larger adipocytes were associated with higher glucose, lower adiponectin and higher CIMT. Particularly, larger adipocytes from SAT were associated with higher blood pressure, lower insulin and HDL-cholesterol; and showed positive correlation with glucose, HbA1c, systolic/diastolic values, and negatively correlated with insulin and adiponectin. VAT's larger adipocytes particularly associated with lower resistin and lower FMD values. Gender and Diabetes Mellitus significantly impacted the relation of adipocyte size/source with the metabolic and atherogenic risk. Multivariable analysis suggested hypertension-resistin-HbA1c interactions associated with SAT's larger adipocytes; whereas potential insulin-adiponectin associations were observed for VAT's larger adipocytes. Adipocyte morphology and source are differentially related with cardiometabolic and atherogenic risk in population with obesity, which are potentially affected by gender and Diabetes Mellitus.
Collapse
Affiliation(s)
- Juan Antonio Suárez-Cuenca
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico.
- Internal Medicine Department, H.G.Z. No. 58 "Manuel Ávila Camacho", IMSS, and Hospital General "Xoco" SS CDMX, 03340, Mexico City, Mexico.
| | - Gustavo De La Peña-Sosa
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Karen De La Vega-Moreno
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Diana Zaineff Banderas-Lares
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Moisés Salamanca-García
- Pathology Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03104, Mexico City, Mexico
| | - José Enrique Martínez-Hernández
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Eduardo Vera-Gómez
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Alejandro Hernández-Patricio
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Carlos Ramiro Zamora-Alemán
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Gabriela Alexandra Domínguez-Pérez
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Atzín Suá Ruíz-Hernández
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Juan Ariel Gutiérrez-Buendía
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Alberto Melchor-López
- Internal Medicine Department, H.G.Z. No. 8 "Gilberto Flores Izquierdo", IMSS and Hospital General "Xoco" SS CDMX, 03340, Mexico City, Mexico
| | - Moisés Ortíz-Fernández
- Bariatric Surgery Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Jesús Montoya-Ramírez
- Bariatric Surgery Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Omar Felipe Gaytán-Fuentes
- Bariatric Surgery Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Angélica Toríz-Ortíz
- Diagnostic Imaging Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Mario Osorio-Valero
- Diagnostic Imaging Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Julita Orozco-Vázquez
- Diagnostic Imaging Department, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | | | | | - Brenda Maldonado-Arriaga
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Rebeca Pérez-Cabeza de Vaca
- Coordination of Research and Tissue Engineering & Regenerative Medicine Research Group, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Mónica Escamilla-Tilch
- Coordination of Research and Tissue Engineering & Regenerative Medicine Research Group, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Juan Antonio Pineda-Juárez
- Coordination of Research and Tissue Engineering & Regenerative Medicine Research Group, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Mario Antonio Téllez-González
- Coordination of Research and Tissue Engineering & Regenerative Medicine Research Group, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| | - Silvia García
- Laboratory of Experimental Metabolism and Clinical Research, Division of Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", ISSSTE, 502, San Lorenzo, Colonia Del Valle, Delegación Benito Juárez, 03100, Mexico City, Mexico
| | - Paul Mondragón-Terán
- Coordination of Research and Tissue Engineering & Regenerative Medicine Research Group, Centro Médico Nacional "20 de Noviembre", ISSSTE, 03100, Mexico City, Mexico
| |
Collapse
|
5
|
Garibay-Vargas OM, Soto-Candía D, Coria-Ramírez E, Castrejón-Vázquez MI, Vargas-Camaño ME, Ramos-Acosta G, Salamanca-García M, Guido-Bayardo RL. [Eosinophilic gastroenteritis]. Rev Alerg Mex 2014; 61:212-218. [PMID: 25177855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023] Open
Abstract
The eosinophilic gastroenteritis is a disease of unknown etiopathogenesis and rare presentation, with several clinical symptoms, ranging from mild episodes until nonspecific abdominal acute episodes of intestinal obstruction, which some times make it necessary urgent surgical treatment. This wide symptomatic range seems to be conditioned by the degree of eosinophilic infiltration of the intestinal wall and the number of layers involved. This paper reports the case of a patient who, due to the diagnosis difficulties, illustrates in a single patient the intestinal and respiratory anatomo-clinical diversity and the evolution of the eosinophilia both intestinal and peripheral. Patient was sent to our service with diagnoses of bronchial asthma, chronic allergic rhinitis and chronic anemia.
Collapse
Affiliation(s)
- Ondina Marlene Garibay-Vargas
- Servicio de Inmunología Clínica y Alergia, Centro Médico Nacional 20 de Noviembre, ISSSTE. Av. Félix Cuevas 540, 03229 México, DF
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Garibay-Vargas OM, Soto-Candia D, Coria-Ramírez E, Castrejón-Vázquez MI, Vargas-Camaño ME, Ramos-Acosta G, Salamanca-García M, Guido-Bayardo RL. Gastroenteritis eosinofílica. RAM 2014. [DOI: 10.29262/ram.v61i3.44] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
La gastroenteritis eosinofílica es una enfermedad de etiopatogenia no aclarada y manifestación poco frecuente, con síntomas clínicos diversos, abarca desde cuadros leves abdominales inespecíficos hasta episodios agudos de obstrucción intestinal que en ocasiones hacen preciso el tratamiento quirúrgico urgente. Este amplio abanico sintomático parece estar condicionado por el grado de infiltración eosinofílica de la pared intestinal y el número de capas afectadas. Comunicamos un caso que por la dificultad diagnóstica ilustra, en un solo paciente, la diversidad anatomo-clínica del cuadro intestinal y respiratorio y la evolución de la eosinofilia intestinal y periférica. La paciente fue enviada a nuestro servicio con los diagnósticos de asma bronquial, rinitis crónica alérgica y anemia crónica persistente.
Collapse
|
7
|
Sánchez-Chávez X, Cortés-Espinosa T, Salamanca-García M, Mata-García OI. [The role of the image on the diagnosis of the gastrointestinal stromal tumor (GIST)]. Rev Gastroenterol Mex 2011; 76:52-54. [PMID: 21592906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Affiliation(s)
- X Sánchez-Chávez
- Gastroenterología, Centro Médico Nacional 20 de Noviembre, ISSSTE.
| | | | | | | |
Collapse
|